文献速递关节外科

模块化金属背衬胫骨组件虽增加成本和使用频率,但中期生存获益甚微:美国关节置换登记数据库的回顾性分析

Modular Metal-Backed Tibial Components Provide Minimal Mid-Term Survivorship Benefits Despite Increased Cost and Frequency of Use: A Retrospective Review of the American Joint Replacement Registry Database.
PubMed 文献 · J Arthroplasty · 2022-02-19

基于美国关节置换登记数据库2012–2019年703,007例初次全膝关节置换术的回顾性分析,比较模块化金属背衬胫骨(MBT)与全聚乙烯胫骨(APT)组件的使用趋势和结局。MBT使用率97.8%、APT为2.2%,APT使用率从2012年5.8%降至2019年1.7%。8年生存率APT 98.1% vs MBT 98.6%,APT全因再手术率高于MBT(1.36% vs 1.00%;比值比1.52)。

要点

  • 研究期间97.8%的初次全膝关节置换术使用MBT组件,APT仅占2.2%。
  • APT使用率从2012年的5.8%下降至2019年的1.7%。
  • 8年生存率APT 98.1% vs MBT 98.6%,APT全因再手术率高于MBT(1.36% vs 1.00%;比值比1.52)。

核心结论

  • 尽管APT使用少且成本较低,其8年生存率与MBT植入物相差在0.4%以内。

研究设计与样本

  • 回顾性查询美国关节置换登记数据库,纳入2012年至2019年研究期间所有初次全膝关节置换术患者,按胫骨组件类型分为APT与MBT队列。
  • 共报告703,007例全膝关节置换术,其中97.8%使用MBT组件,2.2%使用APT组件。
  • 证据等级为III级,回顾性。

主要发现

  • 研究期间APT使用率从2012年的5.8%下降至2019年的1.7%。
  • APT与MBT全膝关节置换术的生存率在研究期间相似:8年生存率APT 98.1% vs MBT 98.6%。
  • APT全因再手术率高于MBT(1.36% vs 1.00%;比值比1.52)。

关键数值与推荐

  • 研究采用国际疾病分类第九版和现行操作术语代码识别再手术率和因感染、无菌性松动、假体周围骨折、麻醉下手法松解及其他原因翻修。
  • 基于再手术原因对APT和MBT进行Kaplan-Meier生存分析。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies have demonstrated equivalent survivorship of modular metal-backed tibial (MBT) and all-polyethylene tibial (APT) components. The purpose of this study is to compare the utilization and outcomes of APT and MBT components in a large US database. METHODS: The American Joint Replacement Registry was queried to identify all patients undergoing primary total knee arthroplasty (TKA) during the study period from 2012 to 2019. These patients were divided into cohorts based on tibial component (APT or MBT). Cohort demographics including gender, hospital size, hospital teaching status, region, age, and Charlson Comorbidity Index were reported with descriptive statistics. Overall reoperation rates and revisions for infection, aseptic loosening, periprosthetic fracture, manipulation under anesthesia, and revision for other reasons were identified using International Classification of Diseases, Ninth Revision and Current Procedural Terminology codes and compared across APT and MBT cohorts. Kaplan-Meir survival analysis was performed based on reason for reoperation for APT and MBT. RESULTS: During the study period, 703,007 TKAs were reported with 97.8% utilizing MBT and 2.2% utilizing APT components. Despite the introduction of alternative payment models during the study period, the utilization of APT decreased from 5.8% in 2012 to 1.7% in 2019. The survival of APT and MBT TKAs were similar across the study period: 98.1% vs 98.6% at 8 years. The rate of reoperation for all-causes was higher for APT compared to MBT (1.36% vs 1.00%; odds ratio 1.52). CONCLUSION: Despite their paucity of use and lower cost APT remained within a 0.4% margin of survivorship when compared to MBT implants for up to 8 years. LEVEL OF EVIDENCE: Level III, retrospective.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Kelley B, Mullen K, De A, et al. Modular Metal-Backed Tibial Components Provide Minimal Mid-Term Survivorship Benefits Despite Increased Cost and Frequency of Use: A Retrospective Review of the American Joint Replacement Registry Database. J Arthroplasty. 2022. PMID: 35189294. doi:10.1016/j.arth.2022.01.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。